IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MISSALE, Mariacristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.153
AS - Asia 8.363
EU - Europa 7.527
SA - Sud America 1.556
Continente sconosciuto - Info sul continente non disponibili 842
AF - Africa 204
OC - Oceania 26
Totale 36.671
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.745
CN - Cina 3.047
SG - Singapore 2.718
UA - Ucraina 1.803
BR - Brasile 1.307
IT - Italia 1.098
PL - Polonia 965
DE - Germania 869
HK - Hong Kong 846
FR - Francia 690
FI - Finlandia 577
GB - Regno Unito 503
VN - Vietnam 495
IN - India 371
TR - Turchia 312
RU - Federazione Russa 298
IE - Irlanda 297
CA - Canada 198
BD - Bangladesh 157
AR - Argentina 81
SE - Svezia 76
IQ - Iraq 67
MX - Messico 67
BE - Belgio 55
CZ - Repubblica Ceca 55
ZA - Sudafrica 53
ID - Indonesia 52
EC - Ecuador 48
JP - Giappone 44
LT - Lituania 38
IR - Iran 36
NL - Olanda 36
ES - Italia 35
CR - Costa Rica 32
PK - Pakistan 32
KR - Corea 29
VE - Venezuela 28
NG - Nigeria 27
CO - Colombia 24
AT - Austria 23
AU - Australia 21
CH - Svizzera 21
KE - Kenya 21
UZ - Uzbekistan 19
CL - Cile 18
EG - Egitto 18
IL - Israele 17
MA - Marocco 17
SA - Arabia Saudita 17
PY - Paraguay 16
TT - Trinidad e Tobago 16
EU - Europa 15
JO - Giordania 14
MU - Mauritius 14
NI - Nicaragua 14
TN - Tunisia 13
GT - Guatemala 12
KZ - Kazakistan 12
PE - Perù 12
UY - Uruguay 12
HN - Honduras 11
JM - Giamaica 11
EE - Estonia 10
ET - Etiopia 10
GP - Guadalupe 10
SC - Seychelles 10
AE - Emirati Arabi Uniti 9
BG - Bulgaria 8
BO - Bolivia 8
DZ - Algeria 8
PR - Porto Rico 8
RO - Romania 8
AZ - Azerbaigian 7
KG - Kirghizistan 7
SV - El Salvador 7
AL - Albania 6
BA - Bosnia-Erzegovina 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
GR - Grecia 6
NP - Nepal 6
PA - Panama 6
PS - Palestinian Territory 6
SK - Slovacchia (Repubblica Slovacca) 6
AM - Armenia 5
HR - Croazia 5
MD - Moldavia 5
MY - Malesia 5
OM - Oman 5
PH - Filippine 5
BB - Barbados 4
CY - Cipro 4
HU - Ungheria 4
RS - Serbia 4
BH - Bahrain 3
CW - ???statistics.table.value.countryCode.CW??? 3
GD - Grenada 3
LB - Libano 3
LU - Lussemburgo 3
LV - Lettonia 3
Totale 35.803
Salva come PNG Salva come JPEG
Città #
Ashburn 1.665
Fairfield 1.570
Woodbridge 1.486
Singapore 1.456
Jacksonville 1.292
Warsaw 954
Houston 921
San Jose 866
Hong Kong 843
Ann Arbor 790
Cambridge 681
Seattle 585
Chandler 579
Wilmington 573
Beijing 536
The Dalles 534
Princeton 527
Council Bluffs 512
Nanjing 466
New York 355
Brescia 338
Dublin 296
Helsinki 290
Dearborn 279
Los Angeles 265
Columbus 256
Lauterbourg 249
Istanbul 239
Nanchang 182
Ho Chi Minh City 159
Shenyang 148
Munich 141
Dallas 131
Des Moines 131
Hebei 131
Milan 129
São Paulo 126
Buffalo 122
Moscow 117
Santa Clara 113
Tianjin 106
Hanoi 104
Jinan 98
Shanghai 94
Changsha 92
San Francisco 89
Toronto 84
San Diego 80
Chicago 78
Pune 73
Jiaxing 69
Orem 68
Lancaster 66
London 62
Redondo Beach 61
Kunming 51
Rome 49
San Mateo 48
Brussels 47
Turku 47
Hangzhou 46
Verona 46
Phoenix 44
Dong Ket 42
Brooklyn 41
Denver 41
Ningbo 41
Rio de Janeiro 39
Tokyo 39
Brno 38
Montreal 38
Kocaeli 36
Augusta 35
Guangzhou 35
Frankfurt am Main 34
Vilnius 34
Atlanta 33
Ardabil 32
Leawood 32
Zhengzhou 32
Brasília 31
North Bergen 31
San Donà Di Piave 31
Boardman 30
Haikou 28
Johannesburg 28
Monmouth Junction 27
Poplar 27
San José 27
Taizhou 27
Abuja 26
Manchester 25
Norwalk 24
Mexico City 23
Romola 23
Mumbai 22
Lanzhou 21
Belo Horizonte 20
Charlotte 19
Chennai 19
Totale 23.766
Salva come PNG Salva come JPEG
Nome #
Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson’s disease 332
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 309
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 304
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways 290
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 276
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 269
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 269
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 263
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. 255
The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissues 243
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 240
Alpha-synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure 237
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 220
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 213
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 207
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation 200
The D3 dopamine receptor: From structural interactions to function. 197
A new pharmacological approach to the facilitation of acetylcholine transmission. 197
Palbociclib inhibits proliferation of human adrenocortical tumor cells 196
The proximity ligation assay: an high throughput technique for protein analysis in neuroscience 194
Lack of coupling of D2 receptors to adenylate cyclase in GH3 cells exposed to epidermal growth factor. Possible role of a differential expression of Gi protein subtypes 191
Age-related changes of enkephalin in rat spinal cord 190
[Functional relation of dopamine receptor stimulation and ionic fluxes in lactotroph cells]. 185
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 185
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease 184
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease 184
From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease 183
Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons 181
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 180
Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia 179
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 178
Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex 176
Age-dependent changes in the mechanisms regulating dopamine uptake in the CNS 176
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity 176
A superfusion method for the study of calcium fluxes from pituitary cells. 175
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 174
Synapsin III alterations in Parkinson's disease 174
Nerve growth factor suppresses the transforming phenotype of human prolactinomas 173
Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. 173
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 173
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 172
Synapsin III and Alpha-Synuclein cooperation in the onset of synaptic pathology in Parkinson’s Disease 171
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 170
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 170
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 170
ALPHA-SYNUCLEIN MODULATES SYNAPSIN III IN NIGROSTRIATAL DOPAMINERGIC NEURONS: IMPLICATIONS FOR PARKINSON'S DISEASE 169
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 169
Identification of neurotensin receptors associated with calcium channels and prolactin release in rat pituitary. 168
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization. 167
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 167
Stimulation of dopamine D-2 receptors increases potassium permeability in mammotrophs. 164
Caveolins in rhabdomyosarcoma 163
Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line 162
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 161
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer 160
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 158
Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro 157
Ormoni Anteroipofisari 157
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 156
The NMDA/D1 receptor complex as a new target in drug development 155
Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function 154
Acute hemodynamic and neurohumoral effects of the oral dopamine derivative ibopamine in patients with heart failure. 153
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 152
Chronic lead exposure differentially affects dopamine transport in rat striatum and nucleus accumbens. 152
Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system. 152
Neuropeptidergic inhibitory regulation of met-enkephalin immunoreactive material release from rat spinal cord in vitro. 151
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 151
Synapsin III Alteration in Parkinson's disease 151
Chronic lead exposure alters dopaminergic mechanisms in rat pituitary 150
Synapsin III Alteration in Parkinson's disease 150
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 149
Critical role of dopamine D3 receptor in structural plasticity generated by exposure to drugs of addiction in mesencephalic dopaminergic neurons 149
PGRN gene silencing in primary neuronal cultures: a model of FTLD-U 149
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 149
Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression 149
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas 148
CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction 148
Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures 148
Afferent fibers mediate the increse of met-enkephalin elicited in rat spinal cord by localized pain. 147
D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP. 147
Pharmacological basis for dopamine D-2 receptor diversity 146
[Dopaminergic receptors in the cardiovascular system: their biochemical characterization and pharmacological importance]. 144
Properties of benzodiazepine binding sites in peripheral blood lymphocytes 144
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 144
Different neurotransmitter systems are involved in the development of esophageal achalasia 143
Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease. 143
Identification of D2 dopaminergic receptors in bovine adrenal cortex. 143
Dopamine D3 receptor heteromerization: Implications for neuroplasticity and neuroprotection 143
Sex-related variations in serum nerve growth factor concentration in humans. 142
Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson’s disease 142
Effect of suloctidil on dopaminergic transmission in various rat brain areas: possible uses as a drug for the elderly 142
Evidence for the presence of D1 and D2 dopamine receptors in the rat adrenal cortex 142
Dopamine D3 receptors are critically involved in the neurotrophic effects of cocaine and nicotine on the mouse mesencephalic dopaminergic neurons 141
Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation. 140
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 140
Establishment and characterization of induced pluripotent stem cell (iPSCs) line UNIBSi014-A from a healthy female donor 139
Nerve growth factor signaling in prostate health and disease. 139
Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter 138
Dopamine receptors and brain function 138
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization 138
Totale 17.617
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.680
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.452 0 0 0 72 16 49 138 121 88 277 177 514
2022/20231.786 306 18 38 139 151 527 5 161 274 39 61 67
2023/20241.763 110 32 142 132 93 372 60 53 387 30 44 308
2024/20254.242 23 46 58 545 471 346 407 105 511 286 877 567
2025/20268.233 753 1.112 658 1.335 755 558 1.229 322 495 686 218 112
2026/20272.945 432 419 837 1.257 0 0 0 0 0 0 0 0
Totale 36.671